Adhesion mechanism of human β2-glycoprotein I to phospholipids based on its crystal structure

EMBO Journal

Volumn 18, Issue 19, 1999, Pages 5166-5174

  Bouma, Barend ^a   De Groot, Philip G ^b   Van Den Elsen, Jean M H ^a   Ravelli, Raimond B G ^c   Schouten, Arie ^a   Simmelink, Marleen J A ^b   Derksen, Ronald H W M ^b   Kroon, Jan ^a   Gros, Piet ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c EUROPEAN MOLECULAR BIOLOGY LABORATORY   (France)

Author keywords

Anti phospholipid antibodies; Apolipoprotein H; Beta2 glycoprotein I; Membrane binding; Short consensus repeat

Indexed keywords

BETA2 GLYCOPROTEIN 1; CELL ADHESION MOLECULE; MEMBRANE PHOSPHOLIPID; MEMBRANE PROTEIN; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY; PLASMA PROTEIN;

AMINO TERMINAL SEQUENCE; ANTIGEN BINDING; ARTICLE; BINDING SITE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; CRYSTAL STRUCTURE; DISULFIDE BOND; HUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN FOLDING; PROTEIN ISOLATION; PROTEIN LIPID INTERACTION;

ANTIBODIES, ANTIPHOSPHOLIPID; BETA 2-GLYCOPROTEIN I; CRYSTALLOGRAPHY, X-RAY; GLYCOPROTEINS; HUMANS; MODELS, MOLECULAR; OLIGOSACCHARIDES; PHOSPHOLIPIDS; PROTEIN BINDING; PROTEIN CONFORMATION;

EID: 0033214106     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/18.19.5166     Document Type: Article

References (61)

1. 2-glycoprotein I macrophage interactions. J. Biol. Chem., 273, 29272-29277.
2. Barlow, P.N., Norman, D.G., Steinkasser, A., Horne, T.J., Pearce, J., Driscoll, P.C., Sim, R.B. and Campbell, I.D. (1992) Solution structure of the fifth repeat of factor H: a second example of the complement control protein module. Biochemistry, 31, 3626-3634.
3. Barlow, P.N., Steinkasser, A., Norman, D.G., Kieffer, B., Wiles, A.P., Sim, R.B. and Campbell, I.D. (1993) Solution structure of a pair of complement modules by nuclear magnetic resonance. J. Mol. Biol., 232, 268-284.
4. Bick, R.L. and Baker, W.F. (1994) Antiphospholipid and thrombosis syndromes. Semin. Thromb. Hemost., 20, 3-15.
5. Blank, M., Shoenfeld, Y., Cabilly, S., Heldman, Y., Fridkin, M. and Katchalski-Katzir, E. (1999) Prevention of experimental antiphospholipid syndrome and endothelial cell activation by synthetic peptides. Proc. Natl Acad. Sci. USA, 96, 5164-5168.
6. Blom, A.M., Webb, J., Villoutreix, B.O. and Dahlbäck, B. (1999) A cluster of positively charged amino acids in the C4BP α-chain is crucial for C4b binding and Factor 1 cofactor function. J. Biol. Chem., 274, 19237-19245.
7. Bodian, D.L., Jones, E.Y., Harlos, K., Stuart, D.I. and Davis, S.J. (1994) Crystal structure of the extracellular region of the human cell adhesion molecule CD2 at 2.5 Å resolution. Structure, 2, 755-766.
8. Bork, P., Downing, K.A., Kieffer, B. and Campbell, I.D. (1996) Structure and distribution of modules in extracellular proteins. Q. Rev. Biophys., 29, 119-167.
9. 2-terminal domains. Science, 260, 979-983.
10. 2-glycoprotein I in thrombosis: evidence for a role as a natural anticoagulant. Br. J. Haematol, 93, 185-194.
11. Brünger, A.T. et al. (1998) Crystallography and NMR system: a new software suite for macromolecular structure determination. Acta Crystallogr. D, 54, 905-921.
12. Casasnovas, J.M., Larvie, M. and Stehle, T. (1999) Crystal structure of two CD46 domains reveals an extended measles virus-binding surface. EMBO J., 18, 2911-2922.
13. (1994) The CCP4 suite: programs for protein crystallography. Acta Crystallogr. D, 50, 760-763.
14. Corpet, F. (1988) Multiple sequence alignment with hierarchical clustering. Nucleic Acids Res., 16, 10881-10890.
15. de Planque, M.R.R., Kruijtzer, J.A.W., Liskamp, R.M.J., Marsh, D., Greathouse, D.V., Koeppe, R.E., de Kruijff, B. and Killian, J.A. (1999) Different membrane anchoring positions of tryptophan and lysine in synthetic transmembrane a-helical peptides. J. Biol. Chem., 274, 20839-20847.
16. Di Scipio, R.G. (1992) Ultrastructures and interactions of complement factors H and I. J. Immunol., 149, 2592-2599.
17. Esmon, N.L., Smirnov, M.D. and Esmon, C.T. (1997) Thrombogenic mechanisms of antiphospholipid antibodies. Thromb. Haemost., 78, 79-82.
18. Galli, M., Comfurius, P., Maassen, C., Hemker, H.C., de Baets, M.H., van Breda-Vriesman, P.J.C., Barbui, T., Zwaal, R.F.A. and Bevers, E.M. (1990) Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor. Lancet, 335, 1544-1547.
19. Gambino, R., Ruiu, G., Pagano, G. and Cassader, M. (1997) Qualitative analysis of the carbohydrate composition of apolipoprotein H. J. Protein Chem., 16, 205-212.
20. 2GPI in antibody binding. J. Immunol., 160, 3917-3923.
21. Hansen, J.E., Lund, O., Engelbrecht, J., Bohr, H., Nielsen, J.O., Hansen, J.E.S. and Brunak, S. (1995) Prediction of O-glycosylation of mammalian proteins: specificity patterns of UDP-GalNac:polypeptide N-acetylgalactosaminyltransferase. Biochem. J., 308, 801-813.
22. Horbach, D.A., van Oort, E., Donders, R.C.J.M., Derksen, R.H.W.M. and de Groot, P.G. (1996) Lupus anticoagulant is the strongest risk factor for both venous and arterial thrombosis in patients with systematic lupus erythematosus - comparison between different assays for detection of antiphospholipid antibodies. Thromb. Haemost., 76, 916-924.
23. 2-glycoprotein I in human plasma. Thromb. Haemost., 80, 791-798.
24. 2-glycoprotein I is proteolytically cleaved in vivo upon activation of fibrinolysis. Thromb. Haemost., 81, 87-95.
25. 2-glycoprolein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies. J. Immunol., 152, 653-659.
26. 2-glycoprotein I critical for lipid binding and anti-cardiolipin antibody cofactor activity. Proc. Natl Acad. Sci. USA, 90, 2141-2145.
27. Iverson, G.M., Victoria, E.J. and Marquis, D.M. (1998) Anti-β2 glycoprotein I (β2GPI) autoantibodies recognize an epitope on the first domain of β2GPI. Proc. Natl Acad. Sci. USA, 195, 15542-15546.
28. Iwata, K., Seya, T., Yanagi, Y., Pesando, J.M., Johnson, P.M., Okabe, M., Ueda, S., Ariga, H. and Nagasawa, S. (1995) Diversity of sites for measles virus binding and for inactivation of complement C3b and C4b on membrane cofactor protein CD46. J. Biol. Chem., 270, 15148-15152.
29. Jones, T.A., Zou, J.Y., Cowan, S.W. and Kjeldgaard, M. (1991) Improved methods for the building of protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A, 47, 110-119.
30. Koike, T., Ichikawa, K., Kasahara, H., Atsumi, T., Tsutsumi, A. and Matsuura, E. (1998) Epitopes on β2-GPI recognized by anticardiolipin antibodies. Lupus, 7 (Suppl. 2), 14-17.
31. Kraulis, P. (1991) Molscript: a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr., 24, 946-950.
32. 2-glycoprotein I cDNA. FEBS Lett., 289, 183-186.
33. Laskowski, R.A., MacArthur, M.W., Moss, D.S. and Thornton, J.M. (1993) PROCHECK - a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr., 26, 283-291.
34. Leahy, D.J., Aukhil, I. and Erickson, H.P. (1996) 2.0 Å crystal structure of a four-domain segment of human fibronectin encompassing the RGD loop and synergy region. Cell, 84, 155-164.
35. 2-glycoprotein I. Proc. Natl Acad. Sci. USA, 81, 3640-3644.
36. Mall, S., Sharma, R.P., East, J.M. and Lee, A.G. (1998) Lipid-protein interactions in the membrane: studies with model peptides. Faraday Discuss., 111, 127-136.
37. 2-glycoprotein I. Arthritis Rheum., 41, 215-223.
38. Mangavel, C., Maget-Dana, R., Tauc, P., Brochon, J.C., Sy, D. and Reynaud, J.A. (1998) Structural investigations of basic amphipathic model peptides in the presence of lipid vesicles studied by circular dichroism, fluorescence, monolayer and modeling. Biochim. Biophys. Acta, 1371, 265-283.
39. Moore, M.D., DiScipio, R.G., Cooper, N.R. and Nemarrow, G.R. (1989) Hydrodynamic electron microscopic and ligand-binding analysis of the Epstein-Barr virus/C3dg receptor (CR2). J. Biol. Chem., 264, 20576-20582.
40. 2-Glycoprotein I modulates the anticoagulant activity of activated protein C on the phospholipid surface. Thromb. Haemost., 75, 49-55.
41. Nicholls A., Sharp, K.A. and Honig, B. (1993) GRASP: graphical representation and analysis of surface properties. Biophys. J., 64, 166-170.
42. Norman, D.G., Barlow, P.N., Baron, M. Day, A.J., Sim, R.B. and Campbell, I.D. (1991) Three dimensional structure of a complement control protein module in solution. J. Mol. Biol., 219, 717-725.
43. Otwinowski, Z. and Minor, W. (1996) Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol., 276, 307-326.
44. Pannu, N.S. and Read, R.J. (1996) Improved structure refinement through Maximum Likelihood. Acta Crystallogr. A, 52, 659-668.
45. 2-glycoprotein I-dependent manner. J. Immunol., 157, 2201-2208.
46. Ravelli, R.B.G., Sweet, R.M., Skinner, J.M., Duisenberg, A.J.M. and Kroon, J. (1997) STRATEGY: a program to optimize the starting spindle angle and scan range for X-ray data collection. J. Appl. Crystallogr., 30, 551-554.
47. Roubey, R.A.S. (1996) Immunology of the antiphospholipid antibody syndrome. Arthritis Rheum., 39, 1444-1454.
48. 2-glycoprotein I) which affect phospholipid binding. Hum. Mol. Genet., 6, 311-316.
49. Saxena, A., Gries, A., Schwarzenbacher, R., Kostner, G.M., Laggner, P. and Prassl, R. (1998) Crystallization and preliminary X-ray crystallographic studies on apolipoprotein H (β2 glycoprotein-I) from human plasma. Acta Crystallogr. D, 54, 1450-1452.
50. Sharma, A.K. and Pangburn, M.K. (1996) Identification of three physically and functionally distinct binding sites for C3b in human complement factor H by deletion mutagenesis. Proc. Natl Aacd. Sci. USA, 93, 10996-11001.
51. Sheng, Y., Sali, A., Herzog, H., Lahnstein, J. and Krilis, S.A. (1996) Site-directed mutagenesis of recombinant human β2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity. J. Immunol., 157, 3744-3751.
52. 2-glycoprotein I. FEBS Lett., 313, 193-197.
53. Stopar, D., Spruijt, R.B., Wolfs, C.J. and Hemminga, M.A. (1996) Local dynamics of the M13 major coat protein in different membrane-mimicking systems. Biochemistry, 35, 15467-15473.
54. Takeya, H., Mori, T., Gabazza, E.C., Kuroda, K., Deguchi, H., Matsuura, E., Ichkawa, K., Koike, T. and Suzuki, K. (1997) Anti-β2-glycoprotein I (β2GPI) monoclonal antibodies with lupus anticoagulant-like activity enhance the β2GPI binding to phospholipids. J. Clin. Invest., 99, 2260-2268.
55. Terwilliger, T.C. and Berendzen, J. (1999) Automated MAD and MIR structure solution. Acta Crystallogr. D, 55, 849-861.
56. Van der Poel, R.H.L., Meijers, J.C.M. and Bouma, B.N. (1999) Interaction between protein S and complement C4b-binding protein (C4BP). J. Biol. Chem., 274, 15144-15150.
57. Vriend, G. (1990) WHAT IF: A molecular modelling and drug design program. J. Mol. Graph., 8, 52-56.
58. Wallace, A.C., Laskowski, R.A. and Thornton, J.H. (1995) LIGPLOT: a program to generate schematic diagrams of protein-ligand interactions. Protein Eng., 8, 127-134.
59. 2 glycoprotein I antibodies derived from patients with the antiphospholipid syndrome. J. Immunol., 155, 1629-1636.
60. Wiles, A.P., Shaw, G., Bright, J., Perczel, A., Campbell, I.D. and Barlow, P.N. (1997) NMR studies of a viral protein that mimics the regulators of complement activation. J. Mol. Biol., 272, 253-265.
61. Willems, G.M., Janssen, M.P., Pelsers, M.M., Comfurius, P., Galli, M., Zwaal, R.F. and Bevers, E.M. (1996) Role of divalency in the high-affinity binding of anticardiolipin antibody β2-glycoprotein I complexes to lipid membranes. Biochemistry, 35, 13833-13842.